From the impact of Obamacare to cutting-edge research, biotech buyouts to FDA decisions, The Motley Fool's health-care team sits down each week�to discuss the most fascinating developments in health care, and their implications for long-term investors. In this week's edition, the team talks about a potentially landmark Supreme Court ruling, the impact of President Obama's budget on health-care stocks, the next wave of innovation for the pharma industry, and why investors need to pay attention to a small research company from upstate New York.
In the following segment, health-care analyst David Williamson dives into the legal battle between Myriad Genetics and those who question its ability to patent human genes. The Supreme Court is hearing opening arguments, with a decision expected later this summer.
Watch and discover how far the impact of this verdict could reach.
What macro trend was Warren Buffett referring to when he said "this is the tapeworm that's eating at American competitiveness"? Find out in our free report: "What's Really Eating at America's Competitiveness." You'll also discover an idea to profit as companies work to eradicate this efficiency-sucking tapeworm. Just click here for free, immediate access.
Best Logistics Companies To Own In Right Now: Baxter International Inc. (BAX)
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pha rmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.
Advisors' Opinion:- [By CRWE]
Baxter International Inc. (NYSE:BAX) reported that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN).
- [By Holly LaFon]
��Baxter International, Inc. (BAX), a medical supply manufacturer, declined during the quarter due to concerns that it could lose more market share than expected in the hemophilia market.
10 Best Warren Buffett Stocks To Invest In 2014: Synta Pharmaceuticals Corp.(SNTA)
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases. The company has two drug candidates in clinical trials for treating multiple types of cancer and various drug candidates in the preclinical stage of development. Its oncology product portfolio includes Ganetespib, an Hsp90 inhibitor in various phase 1, 2, and 3 clinical trail programs for various types of cancers, including non-small cell lung cancer, gastrointestinal stromal tumors, hematologic cancers, colorectal cancer, gastric cancer, small cell lung cancer, ocular melanoma, pancreatic cancer, prostate cancer, breast cancer, hepatocellular cancer, and solid tumors; Elesclomol, a mitochondria-targeting agent in phase 2 clinical trails for non-small cell lung cancer and ovarian cancer, as well as in phase 1 clinical trail for acut e myeloid leukemia; STA-9584, a vascular disrupting agent in preclinical development stage for prostate cancer; and various Hsp90 inhibitors in preclinical development stage for cancers. The company?s inflammatory diseases product portfolio includes calcium release activated calcium modulator (CRACM) channel inhibitors in preclinical development stage for autoimmune diseases, respiratory conditions, and transplantation; and IL-12/23 inhibitors in lead optimization stage for autoimmune diseases. It has a license agreement with Hoffman-La Roche for the development and commercialization of compounds from CRACM. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.
Advisors' Opinion:- [By Keith Speights]
Hard to say goodbye
Synta Pharmaceuticals (NASDAQ: SNTA ) found out how hard it can be to say goodbye. The company's head of research and development left abruptly this week. Shares of the biotech sank 18% on the news. - [By Lauren Pollock]
Synta Pharmaceuticals Corp.(SNTA) said it intends to offer an unspecified number of shares to the public. The biopharmaceutical company has about 69 million shares outstanding. Shares dropped.
- [By Alex Barinka]
Synta Pharmaceuticals Corp. (SNTA) soared 41 percent to $7.15 for the biggest gain in more than four years. A small trial of its drug in breast cancer met goals warranting expansion of the study.
- [By James E. Brumley]
Looks out Synta Pharmaceuticals Corp. (NASDAQ:SNTA), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), you're on notice too. Corcept Therapeutics Incorporated (NASDAQ:CORT) is nipping at your heels, and better still, shares of the company looks like they're about to dole out a sizeable reward to investors who see the writing on the wall.
10 Best Warren Buffett Stocks To Invest In 2014: BP Prudhoe Bay Royalty Trust (BPT)
BP Prudhoe Bay Royalty Trust operates as a grantor trust in the United States. The company holds overriding royalty interests constituting a non-operational interest in minerals in the Prudhoe Bay oil field located on the North Slope in Alaska. The Prudhoe Bay field extends approximately 12 miles by 27 miles and contains approximately 150,000 gross productive acres. As of December 31, 2012, its estimated net remaining proved reserves were 75.517 million barrels of oil and condensate, of which 70.676 million barrels are proved developed reserves and 4.841 million barrels are proved undeveloped reserves. The company was founded in 1989 and is based in Austin, Texas.
Advisors' Opinion:- [By Rick Munarriz]
BP Prudhoe Bay Royalty Trust (NYSE: BPT ) is also fueling its distributions. The trust's new quarterly payout comes out to $2.4147517 a unit. We're really splitting pennies here, but it's actually a reasonable 4% increase over its earlier rate.
- [By Aaron Levitt]
BP Prudhoe Bay Royalty Trust (BPT): BPT is the largest conventional oil and gas trust in the U.S. and was originally formed in 1989 by BP (BP). The royalty trust collects fees on the first 90,000 barrels of oil collected in the massive Prudhoe Bay oil field located on Alaska’s North Slope. While production in Prudhoe Bay have slipped over the last few years, BPT is expected to continue pumping out dividends for another 15 years. This royalty trust�yields a very hefty 11% based on the last four distributions.
- [By Matt DiLallo]
BP Prudhoe Bay Royalty Trust (NYSE: BPT )
Created in 1989, the property of the BP Prudhoe Bay Royalty Trust consists of an overriding royalty interest of oil and condensate production from BP's Prudhoe Bay oil field located on the North Slope in Alaska. The trust makes quarterly payments to investors of the income after expenses, which can vary each quarter. Over the past year the trust has paid out an average of $2.22 per quarter which would imply a yield of around 9.4%. The key point that investors must understand is that the oil in the field is a finite resource, meaning that it will run out. Under current projections it's expected that the trust will run dry around the year 2029.
10 Best Warren Buffett Stocks To Invest In 2014: China Precision Steel Inc.(CPSL)
China Precision Steel, Inc. engages in the manufacture and sale of high precision cold-rolled steel products primarily in the People?s Republic of China. Its products include high strength and ultra-thin cold-rolled precision steel coils and sheets with reduced thickness ranging from 7.5 mm to 0.03 mm comprising low carbon steel used in steel roofing, food packaging, dry batteries, electronic devices, and kitchen tools; and high carbon steel for automobile parts and components, grinding pieces, saw blades, and weaving needles, as well as for use in microelectronics. The company also provides steel processing for tailor made cold rolled steel products; and heat treatment, and cutting and slitting of medium and high-carbon hot-rolled steel strips not exceeding 7.5 mm thickness. It sells its products to components manufactures and directly to the end-users in China; and exports to Indonesia, Thailand, the Caribbean, Nigeria, and Ethiopia. China Precision Steel, Inc. is headq uartered in Sheung Wan, Hong Kong.
Advisors' Opinion:- [By Luke Jacobi]
These reports have put several other steel companies in play.
Steel Dynamics (NASDAQ: STLD) shares are up 0.44 percent Commercial Metals (NYSE: CMC) shares are up 0.34 percent ArcelorMittal (NYSE: MT) shares are up 1.77 percent China Precision Steel (OTC: CPSL) shares were up 2.7 percentPosted-In: Earnings Commodities Markets Trading Ideas
10 Best Warren Buffett Stocks To Invest In 2014: AutoNation Inc (AN)
AutoNation, Inc. (AutoNation), incorporated on May 30, 1991, is an automotive retailer in the United States. As of December 31, 2011, the Company had three operating segments: Domestic, Import, and Premium Luxury. As of December 31, 2011, it owned and operated 258 new vehicle franchises from 215 stores located in the United States, predominantly in metropolitan markets in the Sunbelt region. Its stores sell 32 different brands of new vehicles. The core brands of vehicles that it sells, representing approximately 90% of the new vehicles that it sold during the year ended December 31, 2011, was manufactured by Ford, Toyota, Nissan, General Motors, Honda, Mercedes-Benz, BMW, and Chrysler. The Company offers a diversified range of automotive products and services, including new vehicles, used vehicles, parts and automotive repair and maintenance services , and automotive finance and insurance products, which includes the arranging of financing for vehicle purchases through third-party finance sources. The Company retailed approximately 400,000 new and used vehicles through its stores in 2011. It acquired one automotive retail franchise and related assets during 2011.
Domestic segment consists of retail automotive franchises that sell new vehicles manufactured by General Motors, Ford, and Chrysler. Its Import segment is comprised of retail automotive franchises that sell new vehicles manufactured primarily by Toyota, Honda, and Nissan. Its Premium Luxury segment is consists of retail automotive franchises that sell new vehicles manufactured primarily by Mercedes-Benz, BMW, and Lexus. The franchises in each segment also sells used vehicles, parts and automotive repair and maintenance services, and automotive finance and insurance products. For the year ended December 31, 2011, Domestic revenue represented 34% of total revenue, Import revenue represented 37% of total revenue, and Premium Luxury revenue represented 28% of total revenue. Corporate and other is consist of its other businesses, incl! uding collision centers, e-commerce activities, and an auction operation, each of which generates revenues, as well as unallocated corporate overhead expenses and retrospective commissions for certain financing and insurance transactions that it arranges under agreements with third parties.
The Company�� stores acquires vehicles for retail sale either directly from the applicable automotive manufacturer or distributor or through dealer trades with other stores of the same franchise. it acquires used vehicles from customer trade-ins, auctions, lease terminations, and other sources. It recondition used vehicles acquired for retail sale at its stores��service facilities and capitalize costs related thereto as used vehicle inventory. Through its VVOs, which are located on existing store facilities, it sells vehicles that it would have traditionally wholesaled with an average retail price lower than that of used vehicles it typically retail. Used vehicles that the Company do not sell at its stores or VVOs generally are sold at wholesale prices through auctions.
The Company offers a variety of automotive finance and insurance products to its customers. The Company arranges for its customers to finance vehicles through installment loans or leases with third-party lenders, including the vehicle manufacturers��and distributors��captive finance subsidiaries, in exchange for a commission payable to the Company. It also offers its customers various vehicle protection products, including extended service contracts, maintenance programs, guaranteed auto protection (GAP, this protection covers the shortfall between a customer�� loan balance and insurance payoff in the event of a casualty), tire and wheel protection, and theft protection products. The vehicle protection products that its stores offers to customers are underwritten and administered by independent third parties, including the vehicle manufacturers��and distributors��captive finance subsidiaries. The Company sells t! he produc! ts on a straight commission basis; however, it also participate in future underwriting profit for certain products pursuant to retrospective commission arrangements. Commissions that it receives from these third-party providers may be subject to chargeback, in full or in part, if products that it sells, such as extended service contracts, are cancelled. Its stores also provide a range of vehicle maintenance, repair, paint, and collision repair services, including warranty work that can be performed only at franchised dealerships and customer-pay service work. The Company has entered into framework agreements with vehicle manufacturers and distributors. It operates each of its new vehicle stores under a franchise agreement with a vehicle manufacturer or distributor.
Advisors' Opinion:- [By U.S. News]
Jin Lee/APAutoNation CEO Mike Jackson If you follow the financial media regularly, you will find daily predictions about the direction of the markets. Breakout, a daily blog on Yahoo Finance's website, is typical of what passes for financial information. On Sept. 6, Breakout's Jeff Macke featured Mike Jackson, the CEO of AutoNation (AN), as his guest. Jackson opined that the economy "has moved into a self-sustaining recovery." He may or may not be correct in that assessment, but relying on his views or the views of others claiming predictive powers is more akin to gambling than investing. Macke's program is no worse than what is dispensed by many of his colleagues in the media. The format is familiar to all of us: Intelligent people in positions of power and influence make rational-sounding statements about the economy, the direction of the market or the merit of a particular stock or fund. What's missing is any data indicating that their views are worthy of consideration, based on a history of accurate past predictions or demonstration of predictive skill (as contrasted with luck). There is ample evidence to the contrary. In a paper published in July 2010, three finance professors from Duke University and Ohio State University published the results of an extensive survey they performed. Each quarter from March 2001 to February 2010, they surveyed "top U.S. financial executives." They asked them to predict one- and 10-year stock market returns and also for their predictions of best- and worst-case outcomes. The data they gathered aggregated 11,600 S&P 500 forecasts. You would think the accumulated expertise of these executives would permit them to make fairly accurate predictions about a commonly used index such as the S&P 500 (^GSPC). The opposite was true. The authors of the study found no correlation between the estimates of these top financial executives and the actual value of the index. In fact, the correlation was negative. When they predic
- [By Monica Wolfe]
Over the past week Lampert reduced his stake in AutoNation (AN). The guru cut his holdings by -3.68% by selling a total of 1,131,093 shares. He sold these shares at an average price of $47.50, and the price is now trading up 4%. Lampert now holds on to 29,576,404 shares, representing 24.37% of the company�� shares outstanding.
- [By Monica Gerson]
AutoNation (NYSE: AN) is estimated to report its Q1 earnings at $0.73 per share on revenue of $4.32 billion.
athenahealth (NASDAQ: ATHN) is projected to post its Q1 earnings at $0.17 per share on revenue of $169.99 million.
10 Best Warren Buffett Stocks To Invest In 2014: Tencent Holdings Ltd (TCEHY)
Tencent Holdings Limited is an investment holding company. The Company and its subsidiaries are principally engaged in the provision of Internet value-added services, mobile and telecommunications value-added services and online advertising services to users in the People�� Republic of China. The Company operates in four segments: Internet value-added services, Mobile and telecommunications value-added services, Online advertising, and Others. As of December 31, 2011, its subsidiaries included Tencent Cyber (Tianjin) Company Limited, Tencent Asset Management Limited, Tencent Technology (Beijing) Company Limited, Tencent Cyber (Shenzhen) Company Limited, Tencent Technology (Shanghai) Company Limited and others. Advisors' Opinion:- [By Damian Illia]
The company has a current ratio of 11.8% which is higher than the one registered by Facebook (FB), InterXion Holding N.V. (INXN) and AOL Inc. (AOL). But for investors looking for a higher ROE, Tencent Holdings Ltd. (TCEHY) could be the option.
- [By Kevin Chen]
In the video below, Fool contributor Kevin Chen details five reasons why SINA may be forever doomed:�
SINA Weibo's daily active users may be exaggerated. Its registered users lag that of competitor Tencent� (NASDAQOTH: TCEHY ) Weibo. Its penetration rate trails Tencent Weibo. Its geographic make-up isn't poised for China's economic growth. Meanwhile, Tencent Weibo is. Renren� (NYSE: RENN ) , the "Facebook of China," and gaming portal�NetEase� (NASDAQ: NTES ) threaten SINA Weibo's viability as a social network.�So before you try to profit from the growing microblogging market in China, watch the video below to learn more about the five things Wall Street overlooks when analyzing SINA.
10 Best Warren Buffett Stocks To Invest In 2014: Songbird Estates PLC (SBEPF.PK)
Songbird Estates plc is engaged in management of its investment in its main subsidiary, Canary Wharf Group plc (Canary Wharf Group), which is the holding company. Canary Wharf Group is engaged in integrated property development, investment and management focusing primarily on the Estate. In London, Canary Wharf Group is engaged through joint ventures in the redevelopment of 20 Fenchurch Street and the Shell Centre. Canary Wharf Group�� investment property portfolio consists of 16 completed properties (out of the approximately 35constructed on the Estate) totaling approximately seven meter square feet of net internal area (NIA). In July 2013, Songbird Estates plc's Canary Wharf Group plc completed the acquisition from Gort Limited (in administration) and Hibernia (2005) Limited (in administration), of 15 Westferry Circus at Canary Wharf. Advisors' Opinion:- [By Mike Arnold]
Brookfield's public assets include a 21% stake (and potentially more given certain warrants held by Brookfield) in General Growth Properties (GGP), a 51% stake in Brookfield Office Properties (BPO), a 36% stake (again, more if certain warrants are exercised) in Rouse Properties (RSE) and 21% stake in Canary Wharf Group Plc, which is majority owned by Songbird Estates Plc (SBEPF.PK).
No comments:
Post a Comment